Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Helical joint venture secures funding for City development

(Sharecast News) - Helical announced on Friday that, in joint venture with Places for London, it had secured a £125m development financing facility from HSBC to fund the construction of 10 King William Street, an over-station office scheme above Bank station in the City of London. The London-listed firm said at the same time that the joint venture had signed a building contract with McLaren, with construction already underway.

It said the development was scheduled for completion in December 2026.

The eight-level office building, the first of three initial sites in Helical's partnership with Places for London, would provide 139,000 square feet of office space, 7,260 square feet of terracing, 1,950 square feet of ancillary retail, and amenities including a 'wellness suite'.

It said the project was targeting the highest environmental, social and governance standards, including BREEAM 'outstanding', NABERS five-star, and WELL 'platinum' certifications.

The financing agreement would span four years with a one-year extension option, and would fund the remaining development costs of the project.

"This facility, secured on competitive terms, highlights the confidence in the London office market for 'best-in-class' assets, rich in tenant amenity, which will be delivered into a supply constrained city core market where we are seeing strong rental growth and increasing momentum behind a more comprehensive 'return to the office'," said Helical chief executive officer Matthew Bonning-Snook.

At 1221 GMT, shares in Helical were up 0.32% at 187.8p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.